Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Replisome genes regulation by anti-tumor miR-101-5p in clear cell renal cell carcinoma.

Yamada Y, Nohata N, Uchida A, Kato M, Arai T, Moriya S, Mizuno K, Kojima S, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2020 Jan 23. doi: 10.1111/cas.14327. [Epub ahead of print]

2.

Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan.

Morita R, Okishio K, Shimizu J, Saito H, Sakai H, Kim YH, Hataji O, Yomota M, Nishio M, Aoe K, Kanai O, Kumagai T, Kibata K, Tsukamoto H, Oizumi S, Fujimoto D, Tanaka H, Mizuno K, Masuda T, Kozuki T, Haku T, Suzuki H, Okamoto I, Hoshiyama H, Ueda J, Ohe Y.

Lung Cancer. 2020 Feb;140:8-18. doi: 10.1016/j.lungcan.2019.11.014. Epub 2019 Nov 20.

3.

Multi-input Synapses, but Not LTP-Strengthened Synapses, Correlate with Hippocampal Memory Storage in Aged Mice.

Aziz W, Kraev I, Mizuno K, Kirby A, Fang T, Rupawala H, Kasbi K, Rothe S, Jozsa F, Rosenblum K, Stewart MG, Giese KP.

Curr Biol. 2019 Nov 4;29(21):3600-3610.e4. doi: 10.1016/j.cub.2019.08.064. Epub 2019 Oct 17.

4.

Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma.

Sanada H, Seki N, Mizuno K, Misono S, Uchida A, Yamada Y, Moriya S, Kikkawa N, Machida K, Kumamoto T, Suetsugu T, Inoue H.

Int J Mol Sci. 2019 Sep 11;20(18). pii: E4482. doi: 10.3390/ijms20184482.

5.

Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase-positive lung cancer.

Tanigawa K, Mizuno K, Kamenohara Y, Unoki T, Misono S, Inoue H.

Respirol Case Rep. 2019 Jun 24;7(7):e00454. doi: 10.1002/rcr2.454. eCollection 2019 Oct.

6.

Molecular Pathogenesis of Gene Regulation by the miR-150 Duplex: miR-150-3p Regulates TNS4 in Lung Adenocarcinoma.

Misono S, Seki N, Mizuno K, Yamada Y, Uchida A, Sanada H, Moriya S, Kikkawa N, Kumamoto T, Suetsugu T, Inoue H.

Cancers (Basel). 2019 Apr 30;11(5). pii: E601. doi: 10.3390/cancers11050601.

7.

Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.

Kuboi Y, Nishimura M, Ikeda W, Nakatani T, Seki Y, Yamaura Y, Ogawa K, Hamaguchi A, Muramoto K, Mizuno K, Ogasawara H, Yamauchi T, Yasuda N, Onodera H, Imai T.

Int Immunol. 2019 Apr 26;31(5):357. doi: 10.1093/intimm/dxz035. No abstract available.

PMID:
31002334
8.

Regulation of KIF2A by Antitumor miR-451a Inhibits Cancer Cell Aggressiveness Features in Lung Squamous Cell Carcinoma.

Uchida A, Seki N, Mizuno K, Yamada Y, Misono S, Sanada H, Kikkawa N, Kumamoto T, Suetsugu T, Inoue H.

Cancers (Basel). 2019 Feb 22;11(2). pii: E258. doi: 10.3390/cancers11020258.

9.

Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.

Kuboi Y, Nishimura M, Ikeda W, Nakatani T, Seki Y, Yamaura Y, Ogawa K, Hamaguchi A, Muramoto K, Mizuno K, Ogasawara H, Yamauchi T, Yasuda N, Onodera H, Imai T.

Int Immunol. 2019 Apr 26;31(5):287-302. doi: 10.1093/intimm/dxz006. Erratum in: Int Immunol. 2019 Apr 26;31(5):357.

PMID:
30668715
10.

Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma.

Uchida A, Seki N, Mizuno K, Misono S, Yamada Y, Kikkawa N, Sanada H, Kumamoto T, Suetsugu T, Inoue H.

Cancer Sci. 2019 Jan;110(1):420-432. doi: 10.1111/cas.13853. Epub 2018 Dec 6.

11.

Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis.

Misono S, Seki N, Mizuno K, Yamada Y, Uchida A, Arai T, Kumamoto T, Sanada H, Suetsugu T, Inoue H.

J Hum Genet. 2018 Oct;63(10):1015-1028. doi: 10.1038/s10038-018-0497-9. Epub 2018 Aug 6.

PMID:
30082847
12.

Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus.

Takahashi E, Indalao IL, Sawabuchi T, Mizuno K, Sakai S, Kimoto T, Kim H, Kido H.

Comp Immunol Microbiol Infect Dis. 2018 Feb;56:6-13. doi: 10.1016/j.cimid.2017.11.002. Epub 2017 Nov 23.

13.

Downregulation of matrix metalloproteinase 14 by the antitumor miRNA, miR-150-5p, inhibits the aggressiveness of lung squamous cell carcinoma cells.

Suetsugu T, Koshizuka K, Seki N, Mizuno K, Okato A, Arai T, Misono S, Uchida A, Kumamoto T, Inoue H.

Int J Oncol. 2018 Mar;52(3):913-924. doi: 10.3892/ijo.2017.4232. Epub 2017 Dec 21.

PMID:
29286099
14.

Cytological features in eight patients with ALK-rearranged lung cancer.

Kuroda N, Ohara M, Wada Y, Yasuoka K, Mizuno K, Yorita K, Obayashi C, Takeuchi K.

Diagn Cytopathol. 2018 Jun;46(6):516-519. doi: 10.1002/dc.23879. Epub 2017 Dec 27.

PMID:
29280331
15.

Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma.

Uchida A, Samukawa T, Kumamoto T, Ohshige M, Hatanaka K, Nakamura Y, Mizuno K, Higashimoto I, Sato M, Inoue H.

BMC Pulm Med. 2017 Dec 12;17(1):195. doi: 10.1186/s12890-017-0534-z.

16.

Prognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis.

Tominaga H, Setoguchi T, Shimada H, Nagano S, Sasaki H, Ishidou Y, Sato M, Mizuno K, Inoue H, Komiya S.

Mol Clin Oncol. 2017 Nov;7(5):897-902. doi: 10.3892/mco.2017.1394. Epub 2017 Aug 25.

17.

Cytological findings of ROS1-rearranged lung adenocarcinoma.

Kuroda N, Tamiya H, Nakatani K, Ide H, Wada Y, Yasuoka K, Ohara M, Mizuno K, Yorita K, Takeuchi K.

Diagn Cytopathol. 2018 Apr;46(4):336-339. doi: 10.1002/dc.23845. Epub 2017 Oct 27.

PMID:
29076659
18.

Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas® EGFR mutation test.

Satouchi M, Tanaka H, Yoshioka H, Shimokawaji T, Mizuno K, Takeda K, Yoshino I, Seto T, Kurata T, Tashiro N, Hagiwara K.

Lung Cancer. 2017 Sep;111:190-194. doi: 10.1016/j.lungcan.2017.07.015. Epub 2017 Jul 11.

19.

Prevention of long-term memory loss after retrieval by an endogenous CaMKII inhibitor.

Vigil FA, Mizuno K, Lucchesi W, Valls-Comamala V, Giese KP.

Sci Rep. 2017 Jun 22;7(1):4040. doi: 10.1038/s41598-017-04355-8.

20.

Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study.

Samukawa T, Matsumoto K, Tsukuya G, Koriyama C, Fukuyama S, Uchida A, Mizuno K, Miyahara H, Kiyohara Y, Ninomiya T, Inoue H.

Int J Chron Obstruct Pulmon Dis. 2017 May 15;12:1469-1481. doi: 10.2147/COPD.S130453. eCollection 2017.

Supplemental Content

Loading ...
Support Center